A Joint Statement from the European Association of Urology Renal Cell Cancer Guidelines Panel and the International Kidney Cancer Coalition : The Rejection of Ipilimumab and Nivolumab for Renal Cancer by the Committee for Medicinal Products for Human Use Does not Change Evidence-based Guideline Recommendations
(2018) In European Urology 74(6). p.849-851
Please use this url to cite or link to this publication:
https://lup.lub.lu.se/record/dc34d3e4-5be5-497a-a6fe-5d2ea69e6b53
- author
- organization
- publishing date
- 2018
- type
- Contribution to journal
- publication status
- published
- subject
- in
- European Urology
- volume
- 74
- issue
- 6
- pages
- 3 pages
- publisher
- Elsevier
- external identifiers
-
- scopus:85056208512
- pmid:30201510
- ISSN
- 0302-2838
- DOI
- 10.1016/j.eururo.2018.08.029
- language
- English
- LU publication?
- yes
- id
- dc34d3e4-5be5-497a-a6fe-5d2ea69e6b53
- date added to LUP
- 2018-11-21 13:21:07
- date last changed
- 2024-09-03 06:47:11
@article{dc34d3e4-5be5-497a-a6fe-5d2ea69e6b53, author = {{Bex, Axel and Albiges, Laurence and Staehler, Michael and Bensalah, Karim and Giles, Rachel H. and Dabestani, Saeed and Hofmann, Fabian and Hora, Milan and Kuczyk, Markus A. and Lam, Thomas B. and Marconi, Lorenzo and Merseburger, Axel S. and Fernández-Pello, Sergio and Tahbaz, Rana and Abu-Ghanem, Yasmin and Volpe, Alessandro and Ljungberg, Börje and Escudier, Bernard and Powles, Thomas}}, issn = {{0302-2838}}, language = {{eng}}, number = {{6}}, pages = {{849--851}}, publisher = {{Elsevier}}, series = {{European Urology}}, title = {{A Joint Statement from the European Association of Urology Renal Cell Cancer Guidelines Panel and the International Kidney Cancer Coalition : The Rejection of Ipilimumab and Nivolumab for Renal Cancer by the Committee for Medicinal Products for Human Use Does not Change Evidence-based Guideline Recommendations}}, url = {{http://dx.doi.org/10.1016/j.eururo.2018.08.029}}, doi = {{10.1016/j.eururo.2018.08.029}}, volume = {{74}}, year = {{2018}}, }